Cytokine profile associated with human chronic schistosomiasis mansoni

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 5, 2004, Pages 21-26

  Magalhães, Andréa ^a   Gonzalez Miranda, Delfin ^b   Gonzalez Miranda, Roberval ^b   Araújo, Maria Ilma ^a   Almeida De Jesus, Adriana ^a   Silva, Angela ^c   Santana, Luciana B ^c   Pearce, Edward ^d   Carvalho, Edgar M ^a   Ribeiro De Jésus, Amélia ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Clínica Gonzalez Miranda LTDA   (Brazil)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hepatic fibrosis; Interleukin 13; Interleukin 5; Schistosomiasis

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 4644293497     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02762004000900004     Document Type: Conference Paper

References (25)

1. Araujo MI, de Jesus AR, Bacellar O, Sabin E, Pearce E, Carvalho EM 1996. Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol 26: 1399-403.
2. Abdel-Wahab MF, Ramzy I, Esmat G, el Kafass H, Strickland GT 1992. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures. J Urol 148: 346-50.
3. Bica I, Hamer DH, Stadecker MJ 2000. Hepatic schistosomiasis. Infect Dis Clin North Am 14: 583-604.
4. Booth M, Mwatha JK, Joseph S, Jones FM, Kadzo H, Ireri E, Kazibwe F, Kemijumbi J, Kariuki C, Kimani G, Ouma JH, Kabatereine NB, Vennervald BJ, Dunne DW 2004, Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol 172: 1295-303.
5. Boros DL, Lukacs NW 1992. The role of egg antigens, cytokines in granuloma formation in murine schistosomiasis mansoni. Mem Inst Oswaldo Cruz 87: 75-79.
6. Cheever AW, Williams ME, Wynn TA, Finkelman FD, Seder RA, Cox TM, Hieny S, Caspar P, Sher A 1994. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 153: 753-759.
7. Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA 2001. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34: 273-282.
8. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104: 777-785.
9. Clark IA 2003. The pathophysiology of falciparum malaria. Pharmacol Ther 99: 221-260.
10. de Jesus AR, Miranda DG, Miranda RG, Araujo I, Magalhaes A, Bacellar M, Carvalho EM 2000. Morbidity associated with Schistosoma mansoni infection determined by ultrasound in an endemic area of Brazil, Caatinga do Moura. Am J Trop Med Hyg 63: 1-4.
11. De Wall-Malefyt HR, Spits JH, Rancarolo M, De Vries J 1993. L-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class Il MHC expression. J Exp Med 174: 915-924.
12. Doumenge JP 1987. Atlas of Global Distribution of Schistosomiasis, Université de Bordeaux Press, Bordeaux, France.
13. Falcão PL, Malaquias LC, Martins-Filho OA, Silveira AM, Passos VM, Prata A, Gazzinelli G, Coffman RL, Correa-Oliveira R 1998. Human schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol 20: 447-454.
14. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, Dessein H, Montero F, Elwali NE, Saeed OK, Magzoub M, Dessein AJ 2002. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 169: 929-936.
15. Monica G, Chiaramonte MM-K, Jacobson BA, Cheever AW, Whitters MJ, Goad MEP, Wong V, Collins M, Donaldson DD, Grusby MJ, Wynn TA 2003. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197: 687-701.
16. Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, Mumo J, Fulford AJ, Jones FM, Butterworth AE, Roberts MB, Dunne DW 1998. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol 160: 1992-1999.
17. Naus CW, Jones FM, Satti MZ, Joseph S, Riley EM, Kimani G, Mwatha JK, Kariuki CH, Ouma JH, Kabatereine NB, Vennervald BJ, Dunne DW 2003. Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum. J Infect Dis 187: 1272-1282.
18. Pearce EJ, James SL, Dalton J, Barrall A, Ramos C, Strand M, Sher A 1986. Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Imunol 137: 3593-3600.
19. Pessoa SB, Martins AV 1978. Parasitologia Medico, 10th ed., Guanabara Koogan, Rio de Janeiro.
20. Ribeiro de Jesus A, Araujo I, Bacellar O, Magalhães A, Pearce E, Harn D, Strand M, Carvalho EM 2000. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun 68: 2797-2803.
21. Ribeiro de Jesus AR, Silva A, Santana LB, Magalhães A, de Jesus AA, de Almeida RP, Rego MA, Burattini MN, Pearce EJ, Carvalho EM 2002. Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis 185: 98-105.
22. Ribeiro de Jesus A, Almeida RP, Bacellar O, Araujo MI, Demeure C, Bina JC, Dessein AJ, Carvalho EM 1993. Correlation between cell-mediated immunity and degree of infection in subjects living in na endemic area of schistosomiasis. Eur J Immunol 23: 152-158.
23. Sabin EA, Araújo MI, Carvalho EM, Pearce EJ 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 173: 269-272.
24. Warren KS 1968. Pathophysiology and pathogenesis of hepatosplenic schistosomiasis mansoni. Bull NY Acad Med 44: 280-294.
25. Warren WD, Fomon JJ, Viamonte M, Zeppa R 1967. Preoperative assessment of portal hypertension. Ann Surg 165: 999-1012.